A Sneak Peek Into OCT New England 2024: A Deep Dive into Innovation, Technology, and Patient Engagement
The 16th Annual Outsourcing in Clinical Trials (OCT) New England conference is just around the corner, offering a dynamic platform for professionals in the pharmaceutical and biotechnology industries to uncover the latest advancements in clinical trials. Taking place in Boston from October 23-24, 2024, this event brings together industry leaders to discuss innovations and […]
Hiring Without Headcount – Rebadging, Payrolling, and Badge Flipping in Pharmaceutical Clinical Research
Introduction The pharmaceutical clinical research industry has undergone significant changes in recent years, with headcount constraints and layoffs becoming common due to economic pressures and restructuring. As companies rebound, they seek flexible resourcing models to maintain operations and sustain clinical trials without increasing permanent headcount. Three key approaches used in this context are rebadging, payrolling, […]
The Fun Guide to FDA CRO Oversight for Sponsors
Clinical trials are serious business—but that doesn’t mean your approach to CRO oversight has to be dry and dull. Let’s take you on a journey through FDA regulations on CRO oversight, and we’ll show you how you can maintain control, ensure compliance, and maybe even save a few bucks, all while keeping things smooth and […]
Sneak Peek: Top Clinical Operations Conferences for 2025
As we move into 2025, clinical operations leaders need to strategically plan their conference attendance to stay on top of industry trends and innovations. From clinical trial management and regulatory updates to innovative technologies and patient-centric research, these events provide invaluable opportunities to learn, network, and grow. Here’s a look at some of the top […]
DPharm 2024 Recap: Key Topics, Challenges, and Solutions
The DPharm 2024 conference was a melting pot of ideas, innovation, and collaboration, offering a platform for industry leaders to discuss emerging trends, challenges, and solutions in clinical trials. For those who couldn’t attend, here’s a recap of the key presentations, their insights, and the future they painted for clinical development. Driving Innovation and […]
Is Clinical Trial Funding Affected by the Disjunction Effect During Election Years?
Introduction The U.S. pharmaceutical industry is significantly regulated by federal policy, which means that changes in government leadership, especially during election years, create uncertainty for companies. This uncertainty often leads to a reduction or delay in funding for long-term clinical trials as companies await regulatory and healthcare policy outcomes. The concept of the “disjunction effect,” […]